Cargando…
Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review
Ovarian cancer is the most common cause of gynecological cancer-related mortality, with the majority of women presenting with advanced disease; although chemotherapeutic advances have improved progression-free survival, conventional treatments offer limited results in terms of long-term responses an...
Autores principales: | Marchetti, Claudia, Palaia, Innocenza, Giorgini, Margherita, De Medici, Caterina, Iadarola, Roberta, Vertechy, Laura, Domenici, Lavinia, Di Donato, Violante, Tomao, Federica, Muzii, Ludovico, Benedetti Panici, Pierluigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096491/ https://www.ncbi.nlm.nih.gov/pubmed/25031539 http://dx.doi.org/10.2147/OTT.S40947 |
Ejemplares similares
-
Systematic lymph node dissection during interval debulking surgery for advanced epithelial ovarian cancer: a systematic review and meta-analysis
por: Caruso, Giuseppe, et al.
Publicado: (2022) -
Comparison of Anogenital Distance and Correlation with Vulvo-vaginal Atrophy: A Pilot Study on Premenopausal and Postmenopausal Women
por: Domenici, Lavinia, et al.
Publicado: (2018) -
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
por: De Felice, Francesca, et al.
Publicado: (2015) -
Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials
por: Marchetti, Claudia, et al.
Publicado: (2015) -
Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?
por: Musacchio, Lucia, et al.
Publicado: (2020)